{
    "Trade/Device Name(s)": [
        "Doripenem 10 \u03bcg, BBL\u2122 Sensi-Disc\u2122 Antimicrobial Susceptibility Test Disks"
    ],
    "Submitter Information": "Becton Dickinson and Company",
    "510(k) Number": "K080998",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JTN"
    ],
    "Summary Letter Date": "May 12, 2008",
    "Summary Letter Received Date": "",
    "Submission Date": "April 4, 2008",
    "Regulation Number(s)": [
        "21CFR866.1620"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Disc"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Doripenem",
        "Streptococcus constellatus",
        "Streptococcus intermedius",
        "Acinetobacter baumannii",
        "Escherichia coli",
        "Klebsiella pneumoniae",
        "Proteus mirabilis",
        "Pseudomonas aeruginosa",
        "Staphylococcus aureus (methicillin-susceptible isolates only)",
        "Streptococcus agalactiae",
        "Streptococcus pyogenes",
        "Citrobacter freundii",
        "Enterobacter aerogenes",
        "Enterobacter cloacae",
        "Klebsiella oxytoca",
        "Morganella morganii",
        "Serratia marcescens"
    ],
    "Specimen Type(s)": [
        "Pure culture of bacterial isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Agar diffusion susceptibility test",
        "Paper disk method"
    ],
    "Methodologies": [
        "Zone of inhibition measurement",
        "Semi-quantitative susceptibility testing"
    ],
    "Submission Type(s)": [
        "Disk",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Doripenem 10 \u03bcg BBL\u2122 Sensi-Disc\u2122 antimicrobial susceptibility test disk for in vitro determination of bacterial susceptibility to doripenem",
    "Indications for Use Summary": "For in vitro agar diffusion susceptibility testing to determine bacterial susceptibility to doripenem using specified concentration disks and interpretative criteria",
    "fda_folder": "Microbiology"
}